These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 3946665)
1. Use of MAOIs for demented depressed patients. Jenike MA Am J Psychiatry; 1986 Feb; 143(2):254-5. PubMed ID: 3946665 [No Abstract] [Full Text] [Related]
2. Monoamine oxidase inhibitors as treatment for depressed patients with primary degenerative dementia (Alzheimer's disease). Jenike MA Am J Psychiatry; 1985 Jun; 142(6):763-4. PubMed ID: 4003602 [TBL] [Abstract][Full Text] [Related]
3. Caution urged in using MAOIs with the elderly. Salzman C Am J Psychiatry; 1986 Jan; 143(1):118-9. PubMed ID: 3942267 [No Abstract] [Full Text] [Related]
4. [Adverse drug reactions in combined treatment with tricyclic antidepressants and monoamine oxidase inhibitors]. von Oefele K; Grohmann R; Hippius H; RĂ¼ther E Nervenarzt; 1988 Feb; 59(2):118-23. PubMed ID: 3362260 [No Abstract] [Full Text] [Related]
5. Forms of atypical depression and their response to antidepressant drugs. Davidson J; Pelton S Psychiatry Res; 1986 Feb; 17(2):87-95. PubMed ID: 3083445 [TBL] [Abstract][Full Text] [Related]
6. Use of MAOIs. Shen WW; Nakra R; Park S Hosp Community Psychiatry; 1983 Sep; 34(9):854. PubMed ID: 6618468 [No Abstract] [Full Text] [Related]
7. MAOIs in the contemporary treatment of depression. Thase ME; Trivedi MH; Rush AJ Neuropsychopharmacology; 1995 May; 12(3):185-219. PubMed ID: 7612154 [TBL] [Abstract][Full Text] [Related]
8. On combining TCAs and MAOIs. Grounds D Aust N Z J Psychiatry; 1993 Jun; 27(2):344, 346. PubMed ID: 8363548 [No Abstract] [Full Text] [Related]
12. Current prescription patterns and safety profile of irreversible monoamine oxidase inhibitors: a population-based cohort study of older adults. Shulman KI; Fischer HD; Herrmann N; Huo CY; Anderson GM; Rochon PA J Clin Psychiatry; 2009 Dec; 70(12):1681-6. PubMed ID: 19852903 [TBL] [Abstract][Full Text] [Related]
13. Amitriptyline protects patients on MAOIs from tyramine reactions. Kline NS; Pare M; Hallstrom C; Cooper TB J Clin Psychopharmacol; 1982 Dec; 2(6):434-5. PubMed ID: 7174870 [No Abstract] [Full Text] [Related]
14. Are the monamine oxidase inhibitors facing extinction? O'Reilly RL Can J Psychiatry; 1991 Apr; 36(3):186-9. PubMed ID: 2059937 [TBL] [Abstract][Full Text] [Related]
15. A double-blind placebo-controlled comparison of moclobemide and amitriptyline in the treatment of depression. Bakish D; Wiens A; Ellis J; Alda M; Lapierre Y Can J Psychiatry; 1992 Sep; 37 Suppl 1():12-7. PubMed ID: 1394026 [TBL] [Abstract][Full Text] [Related]
16. The Australian multicentre moclobemide trial. Stanton J Aust N Z J Psychiatry; 1993 Mar; 27(1):158. PubMed ID: 8481158 [No Abstract] [Full Text] [Related]
18. Platelet MAO activity in geriatric patients with depression and dementia. Alexopoulos GS; Young RC; Lieberman KW; Shamoian CA Am J Psychiatry; 1987 Nov; 144(11):1480-3. PubMed ID: 3674232 [TBL] [Abstract][Full Text] [Related]
19. The relationship of acetylation phenotype to treatment with MAOIs: a review. Rose S J Clin Psychopharmacol; 1982 Jun; 2(3):161-4. PubMed ID: 7096607 [TBL] [Abstract][Full Text] [Related]
20. Thyroid functioning during treatment for depression. Kusalic M; Engelsmann F; Bradwejn J J Psychiatry Neurosci; 1993 Nov; 18(5):260-3. PubMed ID: 8297924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]